Global Nuclear Medicine Radioisotopes Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Nuclear Medicine Radioisotopes market size was valued at US$ 3382.6 million in 2023. With growing demand in downstream market, the Nuclear Medicine Radioisotopes is forecast to a readjusted size of US$ 4281.4 million by 2030 with a CAGR of 3.4% during review period.
The research report highlights the growth potential of the global Nuclear Medicine Radioisotopes market. Nuclear Medicine Radioisotopes are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Nuclear Medicine Radioisotopes. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Nuclear Medicine Radioisotopes market.
Nuclear medicine has a huge potential in treating cancer and cardiac diseases. Growth of medical imaging is an opportunity for the growth of the global nuclear medicine radioisotope market, as both markets are correlated. Radiopharmaceuticals are approved by the Food and Drug Administration (FDA) as either drugs or biologics.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Key Features:
The report on Nuclear Medicine Radioisotopes market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Nuclear Medicine Radioisotopes market. It may include historical data, market segmentation by Type (e.g., Thallium-201 (Tl-201), Iodine (I-123)), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Nuclear Medicine Radioisotopes market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Nuclear Medicine Radioisotopes market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Nuclear Medicine Radioisotopes industry. This include advancements in Nuclear Medicine Radioisotopes technology, Nuclear Medicine Radioisotopes new entrants, Nuclear Medicine Radioisotopes new investment, and other innovations that are shaping the future of Nuclear Medicine Radioisotopes.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Nuclear Medicine Radioisotopes market. It includes factors influencing customer ' purchasing decisions, preferences for Nuclear Medicine Radioisotopes product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Nuclear Medicine Radioisotopes market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Nuclear Medicine Radioisotopes market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Nuclear Medicine Radioisotopes market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Nuclear Medicine Radioisotopes industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Nuclear Medicine Radioisotopes market.
Market Segmentation:
Nuclear Medicine Radioisotopes market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Nuclear Medicine Radioisotopes market?
What factors are driving Nuclear Medicine Radioisotopes market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Nuclear Medicine Radioisotopes market opportunities vary by end market size?
How does Nuclear Medicine Radioisotopes break out type, application?
According to our LPI (LP Information) latest study, the global Nuclear Medicine Radioisotopes market size was valued at US$ 3382.6 million in 2023. With growing demand in downstream market, the Nuclear Medicine Radioisotopes is forecast to a readjusted size of US$ 4281.4 million by 2030 with a CAGR of 3.4% during review period.
The research report highlights the growth potential of the global Nuclear Medicine Radioisotopes market. Nuclear Medicine Radioisotopes are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Nuclear Medicine Radioisotopes. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Nuclear Medicine Radioisotopes market.
Nuclear medicine has a huge potential in treating cancer and cardiac diseases. Growth of medical imaging is an opportunity for the growth of the global nuclear medicine radioisotope market, as both markets are correlated. Radiopharmaceuticals are approved by the Food and Drug Administration (FDA) as either drugs or biologics.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Key Features:
The report on Nuclear Medicine Radioisotopes market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Nuclear Medicine Radioisotopes market. It may include historical data, market segmentation by Type (e.g., Thallium-201 (Tl-201), Iodine (I-123)), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Nuclear Medicine Radioisotopes market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Nuclear Medicine Radioisotopes market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Nuclear Medicine Radioisotopes industry. This include advancements in Nuclear Medicine Radioisotopes technology, Nuclear Medicine Radioisotopes new entrants, Nuclear Medicine Radioisotopes new investment, and other innovations that are shaping the future of Nuclear Medicine Radioisotopes.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Nuclear Medicine Radioisotopes market. It includes factors influencing customer ' purchasing decisions, preferences for Nuclear Medicine Radioisotopes product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Nuclear Medicine Radioisotopes market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Nuclear Medicine Radioisotopes market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Nuclear Medicine Radioisotopes market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Nuclear Medicine Radioisotopes industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Nuclear Medicine Radioisotopes market.
Market Segmentation:
Nuclear Medicine Radioisotopes market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- Thallium-201 (Tl-201)
- Iodine (I-123)
- Fluorine-18
- Rubidium-82 (Rb-82)
- Other
- Tumor
- Heart Disease
- Lymphoma
- Thyroid Gland
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Agfa-Gevaert Group
- Braco
- Cardiarc
- Cardinal Health
- CMR Naviscan (Gamma Medica Inc.)
- Curium
- Digirad
- GE Healthcare
- Nordion (Canada)
- NTP Radioisotopes SOC
- Positron
- Segami
- Siemens Healthcare
What is the 10-year outlook for the global Nuclear Medicine Radioisotopes market?
What factors are driving Nuclear Medicine Radioisotopes market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Nuclear Medicine Radioisotopes market opportunities vary by end market size?
How does Nuclear Medicine Radioisotopes break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Nuclear Medicine Radioisotopes Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Nuclear Medicine Radioisotopes by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Nuclear Medicine Radioisotopes by Country/Region, 2019, 2023 & 2030
2.2 Nuclear Medicine Radioisotopes Segment by Type
2.2.1 Thallium-201 (Tl-201)
2.2.2 Iodine (I-123)
2.2.3 Fluorine-18
2.2.4 Rubidium-82 (Rb-82)
2.2.5 Other
2.3 Nuclear Medicine Radioisotopes Sales by Type
2.3.1 Global Nuclear Medicine Radioisotopes Sales Market Share by Type (2019-2024)
2.3.2 Global Nuclear Medicine Radioisotopes Revenue and Market Share by Type (2019-2024)
2.3.3 Global Nuclear Medicine Radioisotopes Sale Price by Type (2019-2024)
2.4 Nuclear Medicine Radioisotopes Segment by Application
2.4.1 Tumor
2.4.2 Heart Disease
2.4.3 Lymphoma
2.4.4 Thyroid Gland
2.4.5 Other
2.5 Nuclear Medicine Radioisotopes Sales by Application
2.5.1 Global Nuclear Medicine Radioisotopes Sale Market Share by Application (2019-2024)
2.5.2 Global Nuclear Medicine Radioisotopes Revenue and Market Share by Application (2019-2024)
2.5.3 Global Nuclear Medicine Radioisotopes Sale Price by Application (2019-2024)
3 GLOBAL NUCLEAR MEDICINE RADIOISOTOPES BY COMPANY
3.1 Global Nuclear Medicine Radioisotopes Breakdown Data by Company
3.1.1 Global Nuclear Medicine Radioisotopes Annual Sales by Company (2019-2024)
3.1.2 Global Nuclear Medicine Radioisotopes Sales Market Share by Company (2019-2024)
3.2 Global Nuclear Medicine Radioisotopes Annual Revenue by Company (2019-2024)
3.2.1 Global Nuclear Medicine Radioisotopes Revenue by Company (2019-2024)
3.2.2 Global Nuclear Medicine Radioisotopes Revenue Market Share by Company (2019-2024)
3.3 Global Nuclear Medicine Radioisotopes Sale Price by Company
3.4 Key Manufacturers Nuclear Medicine Radioisotopes Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Nuclear Medicine Radioisotopes Product Location Distribution
3.4.2 Players Nuclear Medicine Radioisotopes Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR NUCLEAR MEDICINE RADIOISOTOPES BY GEOGRAPHIC REGION
4.1 World Historic Nuclear Medicine Radioisotopes Market Size by Geographic Region (2019-2024)
4.1.1 Global Nuclear Medicine Radioisotopes Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Nuclear Medicine Radioisotopes Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Nuclear Medicine Radioisotopes Market Size by Country/Region (2019-2024)
4.2.1 Global Nuclear Medicine Radioisotopes Annual Sales by Country/Region (2019-2024)
4.2.2 Global Nuclear Medicine Radioisotopes Annual Revenue by Country/Region (2019-2024)
4.3 Americas Nuclear Medicine Radioisotopes Sales Growth
4.4 APAC Nuclear Medicine Radioisotopes Sales Growth
4.5 Europe Nuclear Medicine Radioisotopes Sales Growth
4.6 Middle East & Africa Nuclear Medicine Radioisotopes Sales Growth
5 AMERICAS
5.1 Americas Nuclear Medicine Radioisotopes Sales by Country
5.1.1 Americas Nuclear Medicine Radioisotopes Sales by Country (2019-2024)
5.1.2 Americas Nuclear Medicine Radioisotopes Revenue by Country (2019-2024)
5.2 Americas Nuclear Medicine Radioisotopes Sales by Type
5.3 Americas Nuclear Medicine Radioisotopes Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nuclear Medicine Radioisotopes Sales by Region
6.1.1 APAC Nuclear Medicine Radioisotopes Sales by Region (2019-2024)
6.1.2 APAC Nuclear Medicine Radioisotopes Revenue by Region (2019-2024)
6.2 APAC Nuclear Medicine Radioisotopes Sales by Type
6.3 APAC Nuclear Medicine Radioisotopes Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Nuclear Medicine Radioisotopes by Country
7.1.1 Europe Nuclear Medicine Radioisotopes Sales by Country (2019-2024)
7.1.2 Europe Nuclear Medicine Radioisotopes Revenue by Country (2019-2024)
7.2 Europe Nuclear Medicine Radioisotopes Sales by Type
7.3 Europe Nuclear Medicine Radioisotopes Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Nuclear Medicine Radioisotopes by Country
8.1.1 Middle East & Africa Nuclear Medicine Radioisotopes Sales by Country (2019-2024)
8.1.2 Middle East & Africa Nuclear Medicine Radioisotopes Revenue by Country (2019-2024)
8.2 Middle East & Africa Nuclear Medicine Radioisotopes Sales by Type
8.3 Middle East & Africa Nuclear Medicine Radioisotopes Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Nuclear Medicine Radioisotopes
10.3 Manufacturing Process Analysis of Nuclear Medicine Radioisotopes
10.4 Industry Chain Structure of Nuclear Medicine Radioisotopes
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Nuclear Medicine Radioisotopes Distributors
11.3 Nuclear Medicine Radioisotopes Customer
12 WORLD FORECAST REVIEW FOR NUCLEAR MEDICINE RADIOISOTOPES BY GEOGRAPHIC REGION
12.1 Global Nuclear Medicine Radioisotopes Market Size Forecast by Region
12.1.1 Global Nuclear Medicine Radioisotopes Forecast by Region (2025-2030)
12.1.2 Global Nuclear Medicine Radioisotopes Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Nuclear Medicine Radioisotopes Forecast by Type
12.7 Global Nuclear Medicine Radioisotopes Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Agfa-Gevaert Group
13.1.1 Agfa-Gevaert Group Company Information
13.1.2 Agfa-Gevaert Group Nuclear Medicine Radioisotopes Product Portfolios and Specifications
13.1.3 Agfa-Gevaert Group Nuclear Medicine Radioisotopes Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Agfa-Gevaert Group Main Business Overview
13.1.5 Agfa-Gevaert Group Latest Developments
13.2 Braco
13.2.1 Braco Company Information
13.2.2 Braco Nuclear Medicine Radioisotopes Product Portfolios and Specifications
13.2.3 Braco Nuclear Medicine Radioisotopes Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Braco Main Business Overview
13.2.5 Braco Latest Developments
13.3 Cardiarc
13.3.1 Cardiarc Company Information
13.3.2 Cardiarc Nuclear Medicine Radioisotopes Product Portfolios and Specifications
13.3.3 Cardiarc Nuclear Medicine Radioisotopes Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Cardiarc Main Business Overview
13.3.5 Cardiarc Latest Developments
13.4 Cardinal Health
13.4.1 Cardinal Health Company Information
13.4.2 Cardinal Health Nuclear Medicine Radioisotopes Product Portfolios and Specifications
13.4.3 Cardinal Health Nuclear Medicine Radioisotopes Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Cardinal Health Main Business Overview
13.4.5 Cardinal Health Latest Developments
13.5 CMR Naviscan (Gamma Medica Inc.)
13.5.1 CMR Naviscan (Gamma Medica Inc.) Company Information
13.5.2 CMR Naviscan (Gamma Medica Inc.) Nuclear Medicine Radioisotopes Product Portfolios and Specifications
13.5.3 CMR Naviscan (Gamma Medica Inc.) Nuclear Medicine Radioisotopes Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 CMR Naviscan (Gamma Medica Inc.) Main Business Overview
13.5.5 CMR Naviscan (Gamma Medica Inc.) Latest Developments
13.6 Curium
13.6.1 Curium Company Information
13.6.2 Curium Nuclear Medicine Radioisotopes Product Portfolios and Specifications
13.6.3 Curium Nuclear Medicine Radioisotopes Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Curium Main Business Overview
13.6.5 Curium Latest Developments
13.7 Digirad
13.7.1 Digirad Company Information
13.7.2 Digirad Nuclear Medicine Radioisotopes Product Portfolios and Specifications
13.7.3 Digirad Nuclear Medicine Radioisotopes Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Digirad Main Business Overview
13.7.5 Digirad Latest Developments
13.8 GE Healthcare
13.8.1 GE Healthcare Company Information
13.8.2 GE Healthcare Nuclear Medicine Radioisotopes Product Portfolios and Specifications
13.8.3 GE Healthcare Nuclear Medicine Radioisotopes Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 GE Healthcare Main Business Overview
13.8.5 GE Healthcare Latest Developments
13.9 Nordion (Canada)
13.9.1 Nordion (Canada) Company Information
13.9.2 Nordion (Canada) Nuclear Medicine Radioisotopes Product Portfolios and Specifications
13.9.3 Nordion (Canada) Nuclear Medicine Radioisotopes Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Nordion (Canada) Main Business Overview
13.9.5 Nordion (Canada) Latest Developments
13.10 NTP Radioisotopes SOC
13.10.1 NTP Radioisotopes SOC Company Information
13.10.2 NTP Radioisotopes SOC Nuclear Medicine Radioisotopes Product Portfolios and Specifications
13.10.3 NTP Radioisotopes SOC Nuclear Medicine Radioisotopes Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 NTP Radioisotopes SOC Main Business Overview
13.10.5 NTP Radioisotopes SOC Latest Developments
13.11 Positron
13.11.1 Positron Company Information
13.11.2 Positron Nuclear Medicine Radioisotopes Product Portfolios and Specifications
13.11.3 Positron Nuclear Medicine Radioisotopes Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Positron Main Business Overview
13.11.5 Positron Latest Developments
13.12 Segami
13.12.1 Segami Company Information
13.12.2 Segami Nuclear Medicine Radioisotopes Product Portfolios and Specifications
13.12.3 Segami Nuclear Medicine Radioisotopes Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Segami Main Business Overview
13.12.5 Segami Latest Developments
13.13 Siemens Healthcare
13.13.1 Siemens Healthcare Company Information
13.13.2 Siemens Healthcare Nuclear Medicine Radioisotopes Product Portfolios and Specifications
13.13.3 Siemens Healthcare Nuclear Medicine Radioisotopes Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Siemens Healthcare Main Business Overview
13.13.5 Siemens Healthcare Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Nuclear Medicine Radioisotopes Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Nuclear Medicine Radioisotopes by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Nuclear Medicine Radioisotopes by Country/Region, 2019, 2023 & 2030
2.2 Nuclear Medicine Radioisotopes Segment by Type
2.2.1 Thallium-201 (Tl-201)
2.2.2 Iodine (I-123)
2.2.3 Fluorine-18
2.2.4 Rubidium-82 (Rb-82)
2.2.5 Other
2.3 Nuclear Medicine Radioisotopes Sales by Type
2.3.1 Global Nuclear Medicine Radioisotopes Sales Market Share by Type (2019-2024)
2.3.2 Global Nuclear Medicine Radioisotopes Revenue and Market Share by Type (2019-2024)
2.3.3 Global Nuclear Medicine Radioisotopes Sale Price by Type (2019-2024)
2.4 Nuclear Medicine Radioisotopes Segment by Application
2.4.1 Tumor
2.4.2 Heart Disease
2.4.3 Lymphoma
2.4.4 Thyroid Gland
2.4.5 Other
2.5 Nuclear Medicine Radioisotopes Sales by Application
2.5.1 Global Nuclear Medicine Radioisotopes Sale Market Share by Application (2019-2024)
2.5.2 Global Nuclear Medicine Radioisotopes Revenue and Market Share by Application (2019-2024)
2.5.3 Global Nuclear Medicine Radioisotopes Sale Price by Application (2019-2024)
3 GLOBAL NUCLEAR MEDICINE RADIOISOTOPES BY COMPANY
3.1 Global Nuclear Medicine Radioisotopes Breakdown Data by Company
3.1.1 Global Nuclear Medicine Radioisotopes Annual Sales by Company (2019-2024)
3.1.2 Global Nuclear Medicine Radioisotopes Sales Market Share by Company (2019-2024)
3.2 Global Nuclear Medicine Radioisotopes Annual Revenue by Company (2019-2024)
3.2.1 Global Nuclear Medicine Radioisotopes Revenue by Company (2019-2024)
3.2.2 Global Nuclear Medicine Radioisotopes Revenue Market Share by Company (2019-2024)
3.3 Global Nuclear Medicine Radioisotopes Sale Price by Company
3.4 Key Manufacturers Nuclear Medicine Radioisotopes Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Nuclear Medicine Radioisotopes Product Location Distribution
3.4.2 Players Nuclear Medicine Radioisotopes Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR NUCLEAR MEDICINE RADIOISOTOPES BY GEOGRAPHIC REGION
4.1 World Historic Nuclear Medicine Radioisotopes Market Size by Geographic Region (2019-2024)
4.1.1 Global Nuclear Medicine Radioisotopes Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Nuclear Medicine Radioisotopes Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Nuclear Medicine Radioisotopes Market Size by Country/Region (2019-2024)
4.2.1 Global Nuclear Medicine Radioisotopes Annual Sales by Country/Region (2019-2024)
4.2.2 Global Nuclear Medicine Radioisotopes Annual Revenue by Country/Region (2019-2024)
4.3 Americas Nuclear Medicine Radioisotopes Sales Growth
4.4 APAC Nuclear Medicine Radioisotopes Sales Growth
4.5 Europe Nuclear Medicine Radioisotopes Sales Growth
4.6 Middle East & Africa Nuclear Medicine Radioisotopes Sales Growth
5 AMERICAS
5.1 Americas Nuclear Medicine Radioisotopes Sales by Country
5.1.1 Americas Nuclear Medicine Radioisotopes Sales by Country (2019-2024)
5.1.2 Americas Nuclear Medicine Radioisotopes Revenue by Country (2019-2024)
5.2 Americas Nuclear Medicine Radioisotopes Sales by Type
5.3 Americas Nuclear Medicine Radioisotopes Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nuclear Medicine Radioisotopes Sales by Region
6.1.1 APAC Nuclear Medicine Radioisotopes Sales by Region (2019-2024)
6.1.2 APAC Nuclear Medicine Radioisotopes Revenue by Region (2019-2024)
6.2 APAC Nuclear Medicine Radioisotopes Sales by Type
6.3 APAC Nuclear Medicine Radioisotopes Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Nuclear Medicine Radioisotopes by Country
7.1.1 Europe Nuclear Medicine Radioisotopes Sales by Country (2019-2024)
7.1.2 Europe Nuclear Medicine Radioisotopes Revenue by Country (2019-2024)
7.2 Europe Nuclear Medicine Radioisotopes Sales by Type
7.3 Europe Nuclear Medicine Radioisotopes Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Nuclear Medicine Radioisotopes by Country
8.1.1 Middle East & Africa Nuclear Medicine Radioisotopes Sales by Country (2019-2024)
8.1.2 Middle East & Africa Nuclear Medicine Radioisotopes Revenue by Country (2019-2024)
8.2 Middle East & Africa Nuclear Medicine Radioisotopes Sales by Type
8.3 Middle East & Africa Nuclear Medicine Radioisotopes Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Nuclear Medicine Radioisotopes
10.3 Manufacturing Process Analysis of Nuclear Medicine Radioisotopes
10.4 Industry Chain Structure of Nuclear Medicine Radioisotopes
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Nuclear Medicine Radioisotopes Distributors
11.3 Nuclear Medicine Radioisotopes Customer
12 WORLD FORECAST REVIEW FOR NUCLEAR MEDICINE RADIOISOTOPES BY GEOGRAPHIC REGION
12.1 Global Nuclear Medicine Radioisotopes Market Size Forecast by Region
12.1.1 Global Nuclear Medicine Radioisotopes Forecast by Region (2025-2030)
12.1.2 Global Nuclear Medicine Radioisotopes Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Nuclear Medicine Radioisotopes Forecast by Type
12.7 Global Nuclear Medicine Radioisotopes Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Agfa-Gevaert Group
13.1.1 Agfa-Gevaert Group Company Information
13.1.2 Agfa-Gevaert Group Nuclear Medicine Radioisotopes Product Portfolios and Specifications
13.1.3 Agfa-Gevaert Group Nuclear Medicine Radioisotopes Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Agfa-Gevaert Group Main Business Overview
13.1.5 Agfa-Gevaert Group Latest Developments
13.2 Braco
13.2.1 Braco Company Information
13.2.2 Braco Nuclear Medicine Radioisotopes Product Portfolios and Specifications
13.2.3 Braco Nuclear Medicine Radioisotopes Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Braco Main Business Overview
13.2.5 Braco Latest Developments
13.3 Cardiarc
13.3.1 Cardiarc Company Information
13.3.2 Cardiarc Nuclear Medicine Radioisotopes Product Portfolios and Specifications
13.3.3 Cardiarc Nuclear Medicine Radioisotopes Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Cardiarc Main Business Overview
13.3.5 Cardiarc Latest Developments
13.4 Cardinal Health
13.4.1 Cardinal Health Company Information
13.4.2 Cardinal Health Nuclear Medicine Radioisotopes Product Portfolios and Specifications
13.4.3 Cardinal Health Nuclear Medicine Radioisotopes Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Cardinal Health Main Business Overview
13.4.5 Cardinal Health Latest Developments
13.5 CMR Naviscan (Gamma Medica Inc.)
13.5.1 CMR Naviscan (Gamma Medica Inc.) Company Information
13.5.2 CMR Naviscan (Gamma Medica Inc.) Nuclear Medicine Radioisotopes Product Portfolios and Specifications
13.5.3 CMR Naviscan (Gamma Medica Inc.) Nuclear Medicine Radioisotopes Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 CMR Naviscan (Gamma Medica Inc.) Main Business Overview
13.5.5 CMR Naviscan (Gamma Medica Inc.) Latest Developments
13.6 Curium
13.6.1 Curium Company Information
13.6.2 Curium Nuclear Medicine Radioisotopes Product Portfolios and Specifications
13.6.3 Curium Nuclear Medicine Radioisotopes Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Curium Main Business Overview
13.6.5 Curium Latest Developments
13.7 Digirad
13.7.1 Digirad Company Information
13.7.2 Digirad Nuclear Medicine Radioisotopes Product Portfolios and Specifications
13.7.3 Digirad Nuclear Medicine Radioisotopes Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Digirad Main Business Overview
13.7.5 Digirad Latest Developments
13.8 GE Healthcare
13.8.1 GE Healthcare Company Information
13.8.2 GE Healthcare Nuclear Medicine Radioisotopes Product Portfolios and Specifications
13.8.3 GE Healthcare Nuclear Medicine Radioisotopes Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 GE Healthcare Main Business Overview
13.8.5 GE Healthcare Latest Developments
13.9 Nordion (Canada)
13.9.1 Nordion (Canada) Company Information
13.9.2 Nordion (Canada) Nuclear Medicine Radioisotopes Product Portfolios and Specifications
13.9.3 Nordion (Canada) Nuclear Medicine Radioisotopes Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Nordion (Canada) Main Business Overview
13.9.5 Nordion (Canada) Latest Developments
13.10 NTP Radioisotopes SOC
13.10.1 NTP Radioisotopes SOC Company Information
13.10.2 NTP Radioisotopes SOC Nuclear Medicine Radioisotopes Product Portfolios and Specifications
13.10.3 NTP Radioisotopes SOC Nuclear Medicine Radioisotopes Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 NTP Radioisotopes SOC Main Business Overview
13.10.5 NTP Radioisotopes SOC Latest Developments
13.11 Positron
13.11.1 Positron Company Information
13.11.2 Positron Nuclear Medicine Radioisotopes Product Portfolios and Specifications
13.11.3 Positron Nuclear Medicine Radioisotopes Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Positron Main Business Overview
13.11.5 Positron Latest Developments
13.12 Segami
13.12.1 Segami Company Information
13.12.2 Segami Nuclear Medicine Radioisotopes Product Portfolios and Specifications
13.12.3 Segami Nuclear Medicine Radioisotopes Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Segami Main Business Overview
13.12.5 Segami Latest Developments
13.13 Siemens Healthcare
13.13.1 Siemens Healthcare Company Information
13.13.2 Siemens Healthcare Nuclear Medicine Radioisotopes Product Portfolios and Specifications
13.13.3 Siemens Healthcare Nuclear Medicine Radioisotopes Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Siemens Healthcare Main Business Overview
13.13.5 Siemens Healthcare Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Nuclear Medicine Radioisotopes Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Nuclear Medicine Radioisotopes Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Thallium-201 (Tl-201)
Table 4. Major Players of Iodine (I-123)
Table 5. Major Players of Fluorine-18
Table 6. Major Players of Rubidium-82 (Rb-82)
Table 7. Major Players of Other
Table 8. Global Nuclear Medicine Radioisotopes Sales by Type (2019-2024) & (K Units)
Table 9. Global Nuclear Medicine Radioisotopes Sales Market Share by Type (2019-2024)
Table 10. Global Nuclear Medicine Radioisotopes Revenue by Type (2019-2024) & ($ million)
Table 11. Global Nuclear Medicine Radioisotopes Revenue Market Share by Type (2019-2024)
Table 12. Global Nuclear Medicine Radioisotopes Sale Price by Type (2019-2024) & (USD/Unit)
Table 13. Global Nuclear Medicine Radioisotopes Sales by Application (2019-2024) & (K Units)
Table 14. Global Nuclear Medicine Radioisotopes Sales Market Share by Application (2019-2024)
Table 15. Global Nuclear Medicine Radioisotopes Revenue by Application (2019-2024)
Table 16. Global Nuclear Medicine Radioisotopes Revenue Market Share by Application (2019-2024)
Table 17. Global Nuclear Medicine Radioisotopes Sale Price by Application (2019-2024) & (USD/Unit)
Table 18. Global Nuclear Medicine Radioisotopes Sales by Company (2019-2024) & (K Units)
Table 19. Global Nuclear Medicine Radioisotopes Sales Market Share by Company (2019-2024)
Table 20. Global Nuclear Medicine Radioisotopes Revenue by Company (2019-2024) ($ Millions)
Table 21. Global Nuclear Medicine Radioisotopes Revenue Market Share by Company (2019-2024)
Table 22. Global Nuclear Medicine Radioisotopes Sale Price by Company (2019-2024) & (USD/Unit)
Table 23. Key Manufacturers Nuclear Medicine Radioisotopes Producing Area Distribution and Sales Area
Table 24. Players Nuclear Medicine Radioisotopes Products Offered
Table 25. Nuclear Medicine Radioisotopes Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Nuclear Medicine Radioisotopes Sales by Geographic Region (2019-2024) & (K Units)
Table 29. Global Nuclear Medicine Radioisotopes Sales Market Share Geographic Region (2019-2024)
Table 30. Global Nuclear Medicine Radioisotopes Revenue by Geographic Region (2019-2024) & ($ millions)
Table 31. Global Nuclear Medicine Radioisotopes Revenue Market Share by Geographic Region (2019-2024)
Table 32. Global Nuclear Medicine Radioisotopes Sales by Country/Region (2019-2024) & (K Units)
Table 33. Global Nuclear Medicine Radioisotopes Sales Market Share by Country/Region (2019-2024)
Table 34. Global Nuclear Medicine Radioisotopes Revenue by Country/Region (2019-2024) & ($ millions)
Table 35. Global Nuclear Medicine Radioisotopes Revenue Market Share by Country/Region (2019-2024)
Table 36. Americas Nuclear Medicine Radioisotopes Sales by Country (2019-2024) & (K Units)
Table 37. Americas Nuclear Medicine Radioisotopes Sales Market Share by Country (2019-2024)
Table 38. Americas Nuclear Medicine Radioisotopes Revenue by Country (2019-2024) & ($ Millions)
Table 39. Americas Nuclear Medicine Radioisotopes Revenue Market Share by Country (2019-2024)
Table 40. Americas Nuclear Medicine Radioisotopes Sales by Type (2019-2024) & (K Units)
Table 41. Americas Nuclear Medicine Radioisotopes Sales by Application (2019-2024) & (K Units)
Table 42. APAC Nuclear Medicine Radioisotopes Sales by Region (2019-2024) & (K Units)
Table 43. APAC Nuclear Medicine Radioisotopes Sales Market Share by Region (2019-2024)
Table 44. APAC Nuclear Medicine Radioisotopes Revenue by Region (2019-2024) & ($ Millions)
Table 45. APAC Nuclear Medicine Radioisotopes Revenue Market Share by Region (2019-2024)
Table 46. APAC Nuclear Medicine Radioisotopes Sales by Type (2019-2024) & (K Units)
Table 47. APAC Nuclear Medicine Radioisotopes Sales by Application (2019-2024) & (K Units)
Table 48. Europe Nuclear Medicine Radioisotopes Sales by Country (2019-2024) & (K Units)
Table 49. Europe Nuclear Medicine Radioisotopes Sales Market Share by Country (2019-2024)
Table 50. Europe Nuclear Medicine Radioisotopes Revenue by Country (2019-2024) & ($ Millions)
Table 51. Europe Nuclear Medicine Radioisotopes Revenue Market Share by Country (2019-2024)
Table 52. Europe Nuclear Medicine Radioisotopes Sales by Type (2019-2024) & (K Units)
Table 53. Europe Nuclear Medicine Radioisotopes Sales by Application (2019-2024) & (K Units)
Table 54. Middle East & Africa Nuclear Medicine Radioisotopes Sales by Country (2019-2024) & (K Units)
Table 55. Middle East & Africa Nuclear Medicine Radioisotopes Sales Market Share by Country (2019-2024)
Table 56. Middle East & Africa Nuclear Medicine Radioisotopes Revenue by Country (2019-2024) & ($ Millions)
Table 57. Middle East & Africa Nuclear Medicine Radioisotopes Revenue Market Share by Country (2019-2024)
Table 58. Middle East & Africa Nuclear Medicine Radioisotopes Sales by Type (2019-2024) & (K Units)
Table 59. Middle East & Africa Nuclear Medicine Radioisotopes Sales by Application (2019-2024) & (K Units)
Table 60. Key Market Drivers & Growth Opportunities of Nuclear Medicine Radioisotopes
Table 61. Key Market Challenges & Risks of Nuclear Medicine Radioisotopes
Table 62. Key Industry Trends of Nuclear Medicine Radioisotopes
Table 63. Nuclear Medicine Radioisotopes Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Nuclear Medicine Radioisotopes Distributors List
Table 66. Nuclear Medicine Radioisotopes Customer List
Table 67. Global Nuclear Medicine Radioisotopes Sales Forecast by Region (2025-2030) & (K Units)
Table 68. Global Nuclear Medicine Radioisotopes Revenue Forecast by Region (2025-2030) & ($ millions)
Table 69. Americas Nuclear Medicine Radioisotopes Sales Forecast by Country (2025-2030) & (K Units)
Table 70. Americas Nuclear Medicine Radioisotopes Revenue Forecast by Country (2025-2030) & ($ millions)
Table 71. APAC Nuclear Medicine Radioisotopes Sales Forecast by Region (2025-2030) & (K Units)
Table 72. APAC Nuclear Medicine Radioisotopes Revenue Forecast by Region (2025-2030) & ($ millions)
Table 73. Europe Nuclear Medicine Radioisotopes Sales Forecast by Country (2025-2030) & (K Units)
Table 74. Europe Nuclear Medicine Radioisotopes Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Middle East & Africa Nuclear Medicine Radioisotopes Sales Forecast by Country (2025-2030) & (K Units)
Table 76. Middle East & Africa Nuclear Medicine Radioisotopes Revenue Forecast by Country (2025-2030) & ($ millions)
Table 77. Global Nuclear Medicine Radioisotopes Sales Forecast by Type (2025-2030) & (K Units)
Table 78. Global Nuclear Medicine Radioisotopes Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 79. Global Nuclear Medicine Radioisotopes Sales Forecast by Application (2025-2030) & (K Units)
Table 80. Global Nuclear Medicine Radioisotopes Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 81. Agfa-Gevaert Group Basic Information, Nuclear Medicine Radioisotopes Manufacturing Base, Sales Area and Its Competitors
Table 82. Agfa-Gevaert Group Nuclear Medicine Radioisotopes Product Portfolios and Specifications
Table 83. Agfa-Gevaert Group Nuclear Medicine Radioisotopes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Agfa-Gevaert Group Main Business
Table 85. Agfa-Gevaert Group Latest Developments
Table 86. Braco Basic Information, Nuclear Medicine Radioisotopes Manufacturing Base, Sales Area and Its Competitors
Table 87. Braco Nuclear Medicine Radioisotopes Product Portfolios and Specifications
Table 88. Braco Nuclear Medicine Radioisotopes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Braco Main Business
Table 90. Braco Latest Developments
Table 91. Cardiarc Basic Information, Nuclear Medicine Radioisotopes Manufacturing Base, Sales Area and Its Competitors
Table 92. Cardiarc Nuclear Medicine Radioisotopes Product Portfolios and Specifications
Table 93. Cardiarc Nuclear Medicine Radioisotopes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Cardiarc Main Business
Table 95. Cardiarc Latest Developments
Table 96. Cardinal Health Basic Information, Nuclear Medicine Radioisotopes Manufacturing Base, Sales Area and Its Competitors
Table 97. Cardinal Health Nuclear Medicine Radioisotopes Product Portfolios and Specifications
Table 98. Cardinal Health Nuclear Medicine Radioisotopes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Cardinal Health Main Business
Table 100. Cardinal Health Latest Developments
Table 101. CMR Naviscan (Gamma Medica Inc.) Basic Information, Nuclear Medicine Radioisotopes Manufacturing Base, Sales Area and Its Competitors
Table 102. CMR Naviscan (Gamma Medica Inc.) Nuclear Medicine Radioisotopes Product Portfolios and Specifications
Table 103. CMR Naviscan (Gamma Medica Inc.) Nuclear Medicine Radioisotopes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. CMR Naviscan (Gamma Medica Inc.) Main Business
Table 105. CMR Naviscan (Gamma Medica Inc.) Latest Developments
Table 106. Curium Basic Information, Nuclear Medicine Radioisotopes Manufacturing Base, Sales Area and Its Competitors
Table 107. Curium Nuclear Medicine Radioisotopes Product Portfolios and Specifications
Table 108. Curium Nuclear Medicine Radioisotopes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Curium Main Business
Table 110. Curium Latest Developments
Table 111. Digirad Basic Information, Nuclear Medicine Radioisotopes Manufacturing Base, Sales Area and Its Competitors
Table 112. Digirad Nuclear Medicine Radioisotopes Product Portfolios and Specifications
Table 113. Digirad Nuclear Medicine Radioisotopes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Digirad Main Business
Table 115. Digirad Latest Developments
Table 116. GE Healthcare Basic Information, Nuclear Medicine Radioisotopes Manufacturing Base, Sales Area and Its Competitors
Table 117. GE Healthcare Nuclear Medicine Radioisotopes Product Portfolios and Specifications
Table 118. GE Healthcare Nuclear Medicine Radioisotopes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. GE Healthcare Main Business
Table 120. GE Healthcare Latest Developments
Table 121. Nordion (Canada) Basic Information, Nuclear Medicine Radioisotopes Manufacturing Base, Sales Area and Its Competitors
Table 122. Nordion (Canada) Nuclear Medicine Radioisotopes Product Portfolios and Specifications
Table 123. Nordion (Canada) Nuclear Medicine Radioisotopes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. Nordion (Canada) Main Business
Table 125. Nordion (Canada) Latest Developments
Table 126. NTP Radioisotopes SOC Basic Information, Nuclear Medicine Radioisotopes Manufacturing Base, Sales Area and Its Competitors
Table 127. NTP Radioisotopes SOC Nuclear Medicine Radioisotopes Product Portfolios and Specifications
Table 128. NTP Radioisotopes SOC Nuclear Medicine Radioisotopes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. NTP Radioisotopes SOC Main Business
Table 130. NTP Radioisotopes SOC Latest Developments
Table 131. Positron Basic Information, Nuclear Medicine Radioisotopes Manufacturing Base, Sales Area and Its Competitors
Table 132. Positron Nuclear Medicine Radioisotopes Product Portfolios and Specifications
Table 133. Positron Nuclear Medicine Radioisotopes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 134. Positron Main Business
Table 135. Positron Latest Developments
Table 136. Segami Basic Information, Nuclear Medicine Radioisotopes Manufacturing Base, Sales Area and Its Competitors
Table 137. Segami Nuclear Medicine Radioisotopes Product Portfolios and Specifications
Table 138. Segami Nuclear Medicine Radioisotopes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 139. Segami Main Business
Table 140. Segami Latest Developments
Table 141. Siemens Healthcare Basic Information, Nuclear Medicine Radioisotopes Manufacturing Base, Sales Area and Its Competitors
Table 142. Siemens Healthcare Nuclear Medicine Radioisotopes Product Portfolios and Specifications
Table 143. Siemens Healthcare Nuclear Medicine Radioisotopes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 144. Siemens Healthcare Main Business
Table 145. Siemens Healthcare Latest Developments
Table 1. Nuclear Medicine Radioisotopes Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Nuclear Medicine Radioisotopes Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Thallium-201 (Tl-201)
Table 4. Major Players of Iodine (I-123)
Table 5. Major Players of Fluorine-18
Table 6. Major Players of Rubidium-82 (Rb-82)
Table 7. Major Players of Other
Table 8. Global Nuclear Medicine Radioisotopes Sales by Type (2019-2024) & (K Units)
Table 9. Global Nuclear Medicine Radioisotopes Sales Market Share by Type (2019-2024)
Table 10. Global Nuclear Medicine Radioisotopes Revenue by Type (2019-2024) & ($ million)
Table 11. Global Nuclear Medicine Radioisotopes Revenue Market Share by Type (2019-2024)
Table 12. Global Nuclear Medicine Radioisotopes Sale Price by Type (2019-2024) & (USD/Unit)
Table 13. Global Nuclear Medicine Radioisotopes Sales by Application (2019-2024) & (K Units)
Table 14. Global Nuclear Medicine Radioisotopes Sales Market Share by Application (2019-2024)
Table 15. Global Nuclear Medicine Radioisotopes Revenue by Application (2019-2024)
Table 16. Global Nuclear Medicine Radioisotopes Revenue Market Share by Application (2019-2024)
Table 17. Global Nuclear Medicine Radioisotopes Sale Price by Application (2019-2024) & (USD/Unit)
Table 18. Global Nuclear Medicine Radioisotopes Sales by Company (2019-2024) & (K Units)
Table 19. Global Nuclear Medicine Radioisotopes Sales Market Share by Company (2019-2024)
Table 20. Global Nuclear Medicine Radioisotopes Revenue by Company (2019-2024) ($ Millions)
Table 21. Global Nuclear Medicine Radioisotopes Revenue Market Share by Company (2019-2024)
Table 22. Global Nuclear Medicine Radioisotopes Sale Price by Company (2019-2024) & (USD/Unit)
Table 23. Key Manufacturers Nuclear Medicine Radioisotopes Producing Area Distribution and Sales Area
Table 24. Players Nuclear Medicine Radioisotopes Products Offered
Table 25. Nuclear Medicine Radioisotopes Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Nuclear Medicine Radioisotopes Sales by Geographic Region (2019-2024) & (K Units)
Table 29. Global Nuclear Medicine Radioisotopes Sales Market Share Geographic Region (2019-2024)
Table 30. Global Nuclear Medicine Radioisotopes Revenue by Geographic Region (2019-2024) & ($ millions)
Table 31. Global Nuclear Medicine Radioisotopes Revenue Market Share by Geographic Region (2019-2024)
Table 32. Global Nuclear Medicine Radioisotopes Sales by Country/Region (2019-2024) & (K Units)
Table 33. Global Nuclear Medicine Radioisotopes Sales Market Share by Country/Region (2019-2024)
Table 34. Global Nuclear Medicine Radioisotopes Revenue by Country/Region (2019-2024) & ($ millions)
Table 35. Global Nuclear Medicine Radioisotopes Revenue Market Share by Country/Region (2019-2024)
Table 36. Americas Nuclear Medicine Radioisotopes Sales by Country (2019-2024) & (K Units)
Table 37. Americas Nuclear Medicine Radioisotopes Sales Market Share by Country (2019-2024)
Table 38. Americas Nuclear Medicine Radioisotopes Revenue by Country (2019-2024) & ($ Millions)
Table 39. Americas Nuclear Medicine Radioisotopes Revenue Market Share by Country (2019-2024)
Table 40. Americas Nuclear Medicine Radioisotopes Sales by Type (2019-2024) & (K Units)
Table 41. Americas Nuclear Medicine Radioisotopes Sales by Application (2019-2024) & (K Units)
Table 42. APAC Nuclear Medicine Radioisotopes Sales by Region (2019-2024) & (K Units)
Table 43. APAC Nuclear Medicine Radioisotopes Sales Market Share by Region (2019-2024)
Table 44. APAC Nuclear Medicine Radioisotopes Revenue by Region (2019-2024) & ($ Millions)
Table 45. APAC Nuclear Medicine Radioisotopes Revenue Market Share by Region (2019-2024)
Table 46. APAC Nuclear Medicine Radioisotopes Sales by Type (2019-2024) & (K Units)
Table 47. APAC Nuclear Medicine Radioisotopes Sales by Application (2019-2024) & (K Units)
Table 48. Europe Nuclear Medicine Radioisotopes Sales by Country (2019-2024) & (K Units)
Table 49. Europe Nuclear Medicine Radioisotopes Sales Market Share by Country (2019-2024)
Table 50. Europe Nuclear Medicine Radioisotopes Revenue by Country (2019-2024) & ($ Millions)
Table 51. Europe Nuclear Medicine Radioisotopes Revenue Market Share by Country (2019-2024)
Table 52. Europe Nuclear Medicine Radioisotopes Sales by Type (2019-2024) & (K Units)
Table 53. Europe Nuclear Medicine Radioisotopes Sales by Application (2019-2024) & (K Units)
Table 54. Middle East & Africa Nuclear Medicine Radioisotopes Sales by Country (2019-2024) & (K Units)
Table 55. Middle East & Africa Nuclear Medicine Radioisotopes Sales Market Share by Country (2019-2024)
Table 56. Middle East & Africa Nuclear Medicine Radioisotopes Revenue by Country (2019-2024) & ($ Millions)
Table 57. Middle East & Africa Nuclear Medicine Radioisotopes Revenue Market Share by Country (2019-2024)
Table 58. Middle East & Africa Nuclear Medicine Radioisotopes Sales by Type (2019-2024) & (K Units)
Table 59. Middle East & Africa Nuclear Medicine Radioisotopes Sales by Application (2019-2024) & (K Units)
Table 60. Key Market Drivers & Growth Opportunities of Nuclear Medicine Radioisotopes
Table 61. Key Market Challenges & Risks of Nuclear Medicine Radioisotopes
Table 62. Key Industry Trends of Nuclear Medicine Radioisotopes
Table 63. Nuclear Medicine Radioisotopes Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Nuclear Medicine Radioisotopes Distributors List
Table 66. Nuclear Medicine Radioisotopes Customer List
Table 67. Global Nuclear Medicine Radioisotopes Sales Forecast by Region (2025-2030) & (K Units)
Table 68. Global Nuclear Medicine Radioisotopes Revenue Forecast by Region (2025-2030) & ($ millions)
Table 69. Americas Nuclear Medicine Radioisotopes Sales Forecast by Country (2025-2030) & (K Units)
Table 70. Americas Nuclear Medicine Radioisotopes Revenue Forecast by Country (2025-2030) & ($ millions)
Table 71. APAC Nuclear Medicine Radioisotopes Sales Forecast by Region (2025-2030) & (K Units)
Table 72. APAC Nuclear Medicine Radioisotopes Revenue Forecast by Region (2025-2030) & ($ millions)
Table 73. Europe Nuclear Medicine Radioisotopes Sales Forecast by Country (2025-2030) & (K Units)
Table 74. Europe Nuclear Medicine Radioisotopes Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Middle East & Africa Nuclear Medicine Radioisotopes Sales Forecast by Country (2025-2030) & (K Units)
Table 76. Middle East & Africa Nuclear Medicine Radioisotopes Revenue Forecast by Country (2025-2030) & ($ millions)
Table 77. Global Nuclear Medicine Radioisotopes Sales Forecast by Type (2025-2030) & (K Units)
Table 78. Global Nuclear Medicine Radioisotopes Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 79. Global Nuclear Medicine Radioisotopes Sales Forecast by Application (2025-2030) & (K Units)
Table 80. Global Nuclear Medicine Radioisotopes Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 81. Agfa-Gevaert Group Basic Information, Nuclear Medicine Radioisotopes Manufacturing Base, Sales Area and Its Competitors
Table 82. Agfa-Gevaert Group Nuclear Medicine Radioisotopes Product Portfolios and Specifications
Table 83. Agfa-Gevaert Group Nuclear Medicine Radioisotopes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Agfa-Gevaert Group Main Business
Table 85. Agfa-Gevaert Group Latest Developments
Table 86. Braco Basic Information, Nuclear Medicine Radioisotopes Manufacturing Base, Sales Area and Its Competitors
Table 87. Braco Nuclear Medicine Radioisotopes Product Portfolios and Specifications
Table 88. Braco Nuclear Medicine Radioisotopes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Braco Main Business
Table 90. Braco Latest Developments
Table 91. Cardiarc Basic Information, Nuclear Medicine Radioisotopes Manufacturing Base, Sales Area and Its Competitors
Table 92. Cardiarc Nuclear Medicine Radioisotopes Product Portfolios and Specifications
Table 93. Cardiarc Nuclear Medicine Radioisotopes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Cardiarc Main Business
Table 95. Cardiarc Latest Developments
Table 96. Cardinal Health Basic Information, Nuclear Medicine Radioisotopes Manufacturing Base, Sales Area and Its Competitors
Table 97. Cardinal Health Nuclear Medicine Radioisotopes Product Portfolios and Specifications
Table 98. Cardinal Health Nuclear Medicine Radioisotopes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Cardinal Health Main Business
Table 100. Cardinal Health Latest Developments
Table 101. CMR Naviscan (Gamma Medica Inc.) Basic Information, Nuclear Medicine Radioisotopes Manufacturing Base, Sales Area and Its Competitors
Table 102. CMR Naviscan (Gamma Medica Inc.) Nuclear Medicine Radioisotopes Product Portfolios and Specifications
Table 103. CMR Naviscan (Gamma Medica Inc.) Nuclear Medicine Radioisotopes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. CMR Naviscan (Gamma Medica Inc.) Main Business
Table 105. CMR Naviscan (Gamma Medica Inc.) Latest Developments
Table 106. Curium Basic Information, Nuclear Medicine Radioisotopes Manufacturing Base, Sales Area and Its Competitors
Table 107. Curium Nuclear Medicine Radioisotopes Product Portfolios and Specifications
Table 108. Curium Nuclear Medicine Radioisotopes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Curium Main Business
Table 110. Curium Latest Developments
Table 111. Digirad Basic Information, Nuclear Medicine Radioisotopes Manufacturing Base, Sales Area and Its Competitors
Table 112. Digirad Nuclear Medicine Radioisotopes Product Portfolios and Specifications
Table 113. Digirad Nuclear Medicine Radioisotopes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Digirad Main Business
Table 115. Digirad Latest Developments
Table 116. GE Healthcare Basic Information, Nuclear Medicine Radioisotopes Manufacturing Base, Sales Area and Its Competitors
Table 117. GE Healthcare Nuclear Medicine Radioisotopes Product Portfolios and Specifications
Table 118. GE Healthcare Nuclear Medicine Radioisotopes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. GE Healthcare Main Business
Table 120. GE Healthcare Latest Developments
Table 121. Nordion (Canada) Basic Information, Nuclear Medicine Radioisotopes Manufacturing Base, Sales Area and Its Competitors
Table 122. Nordion (Canada) Nuclear Medicine Radioisotopes Product Portfolios and Specifications
Table 123. Nordion (Canada) Nuclear Medicine Radioisotopes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. Nordion (Canada) Main Business
Table 125. Nordion (Canada) Latest Developments
Table 126. NTP Radioisotopes SOC Basic Information, Nuclear Medicine Radioisotopes Manufacturing Base, Sales Area and Its Competitors
Table 127. NTP Radioisotopes SOC Nuclear Medicine Radioisotopes Product Portfolios and Specifications
Table 128. NTP Radioisotopes SOC Nuclear Medicine Radioisotopes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. NTP Radioisotopes SOC Main Business
Table 130. NTP Radioisotopes SOC Latest Developments
Table 131. Positron Basic Information, Nuclear Medicine Radioisotopes Manufacturing Base, Sales Area and Its Competitors
Table 132. Positron Nuclear Medicine Radioisotopes Product Portfolios and Specifications
Table 133. Positron Nuclear Medicine Radioisotopes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 134. Positron Main Business
Table 135. Positron Latest Developments
Table 136. Segami Basic Information, Nuclear Medicine Radioisotopes Manufacturing Base, Sales Area and Its Competitors
Table 137. Segami Nuclear Medicine Radioisotopes Product Portfolios and Specifications
Table 138. Segami Nuclear Medicine Radioisotopes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 139. Segami Main Business
Table 140. Segami Latest Developments
Table 141. Siemens Healthcare Basic Information, Nuclear Medicine Radioisotopes Manufacturing Base, Sales Area and Its Competitors
Table 142. Siemens Healthcare Nuclear Medicine Radioisotopes Product Portfolios and Specifications
Table 143. Siemens Healthcare Nuclear Medicine Radioisotopes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 144. Siemens Healthcare Main Business
Table 145. Siemens Healthcare Latest Developments
LIST OF FIGURES
Figure 1. Picture of Nuclear Medicine Radioisotopes
Figure 2. Nuclear Medicine Radioisotopes Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Nuclear Medicine Radioisotopes Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Nuclear Medicine Radioisotopes Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Nuclear Medicine Radioisotopes Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Thallium-201 (Tl-201)
Figure 10. Product Picture of Iodine (I-123)
Figure 11. Product Picture of Fluorine-18
Figure 12. Product Picture of Rubidium-82 (Rb-82)
Figure 13. Product Picture of Other
Figure 14. Global Nuclear Medicine Radioisotopes Sales Market Share by Type in 2023
Figure 15. Global Nuclear Medicine Radioisotopes Revenue Market Share by Type (2019-2024)
Figure 16. Nuclear Medicine Radioisotopes Consumed in Tumor
Figure 17. Global Nuclear Medicine Radioisotopes Market: Tumor (2019-2024) & (K Units)
Figure 18. Nuclear Medicine Radioisotopes Consumed in Heart Disease
Figure 19. Global Nuclear Medicine Radioisotopes Market: Heart Disease (2019-2024) & (K Units)
Figure 20. Nuclear Medicine Radioisotopes Consumed in Lymphoma
Figure 21. Global Nuclear Medicine Radioisotopes Market: Lymphoma (2019-2024) & (K Units)
Figure 22. Nuclear Medicine Radioisotopes Consumed in Thyroid Gland
Figure 23. Global Nuclear Medicine Radioisotopes Market: Thyroid Gland (2019-2024) & (K Units)
Figure 24. Nuclear Medicine Radioisotopes Consumed in Other
Figure 25. Global Nuclear Medicine Radioisotopes Market: Other (2019-2024) & (K Units)
Figure 26. Global Nuclear Medicine Radioisotopes Sales Market Share by Application (2023)
Figure 27. Global Nuclear Medicine Radioisotopes Revenue Market Share by Application in 2023
Figure 28. Nuclear Medicine Radioisotopes Sales Market by Company in 2023 (K Units)
Figure 29. Global Nuclear Medicine Radioisotopes Sales Market Share by Company in 2023
Figure 30. Nuclear Medicine Radioisotopes Revenue Market by Company in 2023 ($ Million)
Figure 31. Global Nuclear Medicine Radioisotopes Revenue Market Share by Company in 2023
Figure 32. Global Nuclear Medicine Radioisotopes Sales Market Share by Geographic Region (2019-2024)
Figure 33. Global Nuclear Medicine Radioisotopes Revenue Market Share by Geographic Region in 2023
Figure 34. Americas Nuclear Medicine Radioisotopes Sales 2019-2024 (K Units)
Figure 35. Americas Nuclear Medicine Radioisotopes Revenue 2019-2024 ($ Millions)
Figure 36. APAC Nuclear Medicine Radioisotopes Sales 2019-2024 (K Units)
Figure 37. APAC Nuclear Medicine Radioisotopes Revenue 2019-2024 ($ Millions)
Figure 38. Europe Nuclear Medicine Radioisotopes Sales 2019-2024 (K Units)
Figure 39. Europe Nuclear Medicine Radioisotopes Revenue 2019-2024 ($ Millions)
Figure 40. Middle East & Africa Nuclear Medicine Radioisotopes Sales 2019-2024 (K Units)
Figure 41. Middle East & Africa Nuclear Medicine Radioisotopes Revenue 2019-2024 ($ Millions)
Figure 42. Americas Nuclear Medicine Radioisotopes Sales Market Share by Country in 2023
Figure 43. Americas Nuclear Medicine Radioisotopes Revenue Market Share by Country in 2023
Figure 44. Americas Nuclear Medicine Radioisotopes Sales Market Share by Type (2019-2024)
Figure 45. Americas Nuclear Medicine Radioisotopes Sales Market Share by Application (2019-2024)
Figure 46. United States Nuclear Medicine Radioisotopes Revenue Growth 2019-2024 ($ Millions)
Figure 47. Canada Nuclear Medicine Radioisotopes Revenue Growth 2019-2024 ($ Millions)
Figure 48. Mexico Nuclear Medicine Radioisotopes Revenue Growth 2019-2024 ($ Millions)
Figure 49. Brazil Nuclear Medicine Radioisotopes Revenue Growth 2019-2024 ($ Millions)
Figure 50. APAC Nuclear Medicine Radioisotopes Sales Market Share by Region in 2023
Figure 51. APAC Nuclear Medicine Radioisotopes Revenue Market Share by Regions in 2023
Figure 52. APAC Nuclear Medicine Radioisotopes Sales Market Share by Type (2019-2024)
Figure 53. APAC Nuclear Medicine Radioisotopes Sales Market Share by Application (2019-2024)
Figure 54. China Nuclear Medicine Radioisotopes Revenue Growth 2019-2024 ($ Millions)
Figure 55. Japan Nuclear Medicine Radioisotopes Revenue Growth 2019-2024 ($ Millions)
Figure 56. South Korea Nuclear Medicine Radioisotopes Revenue Growth 2019-2024 ($ Millions)
Figure 57. Southeast Asia Nuclear Medicine Radioisotopes Revenue Growth 2019-2024 ($ Millions)
Figure 58. India Nuclear Medicine Radioisotopes Revenue Growth 2019-2024 ($ Millions)
Figure 59. Australia Nuclear Medicine Radioisotopes Revenue Growth 2019-2024 ($ Millions)
Figure 60. China Taiwan Nuclear Medicine Radioisotopes Revenue Growth 2019-2024 ($ Millions)
Figure 61. Europe Nuclear Medicine Radioisotopes Sales Market Share by Country in 2023
Figure 62. Europe Nuclear Medicine Radioisotopes Revenue Market Share by Country in 2023
Figure 63. Europe Nuclear Medicine Radioisotopes Sales Market Share by Type (2019-2024)
Figure 64. Europe Nuclear Medicine Radioisotopes Sales Market Share by Application (2019-2024)
Figure 65. Germany Nuclear Medicine Radioisotopes Revenue Growth 2019-2024 ($ Millions)
Figure 66. France Nuclear Medicine Radioisotopes Revenue Growth 2019-2024 ($ Millions)
Figure 67. UK Nuclear Medicine Radioisotopes Revenue Growth 2019-2024 ($ Millions)
Figure 68. Italy Nuclear Medicine Radioisotopes Revenue Growth 2019-2024 ($ Millions)
Figure 69. Russia Nuclear Medicine Radioisotopes Revenue Growth 2019-2024 ($ Millions)
Figure 70. Middle East & Africa Nuclear Medicine Radioisotopes Sales Market Share by Country in 2023
Figure 71. Middle East & Africa Nuclear Medicine Radioisotopes Revenue Market Share by Country in 2023
Figure 72. Middle East & Africa Nuclear Medicine Radioisotopes Sales Market Share by Type (2019-2024)
Figure 73. Middle East & Africa Nuclear Medicine Radioisotopes Sales Market Share by Application (2019-2024)
Figure 74. Egypt Nuclear Medicine Radioisotopes Revenue Growth 2019-2024 ($ Millions)
Figure 75. South Africa Nuclear Medicine Radioisotopes Revenue Growth 2019-2024 ($ Millions)
Figure 76. Israel Nuclear Medicine Radioisotopes Revenue Growth 2019-2024 ($ Millions)
Figure 77. Turkey Nuclear Medicine Radioisotopes Revenue Growth 2019-2024 ($ Millions)
Figure 78. GCC Country Nuclear Medicine Radioisotopes Revenue Growth 2019-2024 ($ Millions)
Figure 79. Manufacturing Cost Structure Analysis of Nuclear Medicine Radioisotopes in 2023
Figure 80. Manufacturing Process Analysis of Nuclear Medicine Radioisotopes
Figure 81. Industry Chain Structure of Nuclear Medicine Radioisotopes
Figure 82. Channels of Distribution
Figure 83. Global Nuclear Medicine Radioisotopes Sales Market Forecast by Region (2025-2030)
Figure 84. Global Nuclear Medicine Radioisotopes Revenue Market Share Forecast by Region (2025-2030)
Figure 85. Global Nuclear Medicine Radioisotopes Sales Market Share Forecast by Type (2025-2030)
Figure 86. Global Nuclear Medicine Radioisotopes Revenue Market Share Forecast by Type (2025-2030)
Figure 87. Global Nuclear Medicine Radioisotopes Sales Market Share Forecast by Application (2025-2030)
Figure 88. Global Nuclear Medicine Radioisotopes Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Nuclear Medicine Radioisotopes
Figure 2. Nuclear Medicine Radioisotopes Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Nuclear Medicine Radioisotopes Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Nuclear Medicine Radioisotopes Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Nuclear Medicine Radioisotopes Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Thallium-201 (Tl-201)
Figure 10. Product Picture of Iodine (I-123)
Figure 11. Product Picture of Fluorine-18
Figure 12. Product Picture of Rubidium-82 (Rb-82)
Figure 13. Product Picture of Other
Figure 14. Global Nuclear Medicine Radioisotopes Sales Market Share by Type in 2023
Figure 15. Global Nuclear Medicine Radioisotopes Revenue Market Share by Type (2019-2024)
Figure 16. Nuclear Medicine Radioisotopes Consumed in Tumor
Figure 17. Global Nuclear Medicine Radioisotopes Market: Tumor (2019-2024) & (K Units)
Figure 18. Nuclear Medicine Radioisotopes Consumed in Heart Disease
Figure 19. Global Nuclear Medicine Radioisotopes Market: Heart Disease (2019-2024) & (K Units)
Figure 20. Nuclear Medicine Radioisotopes Consumed in Lymphoma
Figure 21. Global Nuclear Medicine Radioisotopes Market: Lymphoma (2019-2024) & (K Units)
Figure 22. Nuclear Medicine Radioisotopes Consumed in Thyroid Gland
Figure 23. Global Nuclear Medicine Radioisotopes Market: Thyroid Gland (2019-2024) & (K Units)
Figure 24. Nuclear Medicine Radioisotopes Consumed in Other
Figure 25. Global Nuclear Medicine Radioisotopes Market: Other (2019-2024) & (K Units)
Figure 26. Global Nuclear Medicine Radioisotopes Sales Market Share by Application (2023)
Figure 27. Global Nuclear Medicine Radioisotopes Revenue Market Share by Application in 2023
Figure 28. Nuclear Medicine Radioisotopes Sales Market by Company in 2023 (K Units)
Figure 29. Global Nuclear Medicine Radioisotopes Sales Market Share by Company in 2023
Figure 30. Nuclear Medicine Radioisotopes Revenue Market by Company in 2023 ($ Million)
Figure 31. Global Nuclear Medicine Radioisotopes Revenue Market Share by Company in 2023
Figure 32. Global Nuclear Medicine Radioisotopes Sales Market Share by Geographic Region (2019-2024)
Figure 33. Global Nuclear Medicine Radioisotopes Revenue Market Share by Geographic Region in 2023
Figure 34. Americas Nuclear Medicine Radioisotopes Sales 2019-2024 (K Units)
Figure 35. Americas Nuclear Medicine Radioisotopes Revenue 2019-2024 ($ Millions)
Figure 36. APAC Nuclear Medicine Radioisotopes Sales 2019-2024 (K Units)
Figure 37. APAC Nuclear Medicine Radioisotopes Revenue 2019-2024 ($ Millions)
Figure 38. Europe Nuclear Medicine Radioisotopes Sales 2019-2024 (K Units)
Figure 39. Europe Nuclear Medicine Radioisotopes Revenue 2019-2024 ($ Millions)
Figure 40. Middle East & Africa Nuclear Medicine Radioisotopes Sales 2019-2024 (K Units)
Figure 41. Middle East & Africa Nuclear Medicine Radioisotopes Revenue 2019-2024 ($ Millions)
Figure 42. Americas Nuclear Medicine Radioisotopes Sales Market Share by Country in 2023
Figure 43. Americas Nuclear Medicine Radioisotopes Revenue Market Share by Country in 2023
Figure 44. Americas Nuclear Medicine Radioisotopes Sales Market Share by Type (2019-2024)
Figure 45. Americas Nuclear Medicine Radioisotopes Sales Market Share by Application (2019-2024)
Figure 46. United States Nuclear Medicine Radioisotopes Revenue Growth 2019-2024 ($ Millions)
Figure 47. Canada Nuclear Medicine Radioisotopes Revenue Growth 2019-2024 ($ Millions)
Figure 48. Mexico Nuclear Medicine Radioisotopes Revenue Growth 2019-2024 ($ Millions)
Figure 49. Brazil Nuclear Medicine Radioisotopes Revenue Growth 2019-2024 ($ Millions)
Figure 50. APAC Nuclear Medicine Radioisotopes Sales Market Share by Region in 2023
Figure 51. APAC Nuclear Medicine Radioisotopes Revenue Market Share by Regions in 2023
Figure 52. APAC Nuclear Medicine Radioisotopes Sales Market Share by Type (2019-2024)
Figure 53. APAC Nuclear Medicine Radioisotopes Sales Market Share by Application (2019-2024)
Figure 54. China Nuclear Medicine Radioisotopes Revenue Growth 2019-2024 ($ Millions)
Figure 55. Japan Nuclear Medicine Radioisotopes Revenue Growth 2019-2024 ($ Millions)
Figure 56. South Korea Nuclear Medicine Radioisotopes Revenue Growth 2019-2024 ($ Millions)
Figure 57. Southeast Asia Nuclear Medicine Radioisotopes Revenue Growth 2019-2024 ($ Millions)
Figure 58. India Nuclear Medicine Radioisotopes Revenue Growth 2019-2024 ($ Millions)
Figure 59. Australia Nuclear Medicine Radioisotopes Revenue Growth 2019-2024 ($ Millions)
Figure 60. China Taiwan Nuclear Medicine Radioisotopes Revenue Growth 2019-2024 ($ Millions)
Figure 61. Europe Nuclear Medicine Radioisotopes Sales Market Share by Country in 2023
Figure 62. Europe Nuclear Medicine Radioisotopes Revenue Market Share by Country in 2023
Figure 63. Europe Nuclear Medicine Radioisotopes Sales Market Share by Type (2019-2024)
Figure 64. Europe Nuclear Medicine Radioisotopes Sales Market Share by Application (2019-2024)
Figure 65. Germany Nuclear Medicine Radioisotopes Revenue Growth 2019-2024 ($ Millions)
Figure 66. France Nuclear Medicine Radioisotopes Revenue Growth 2019-2024 ($ Millions)
Figure 67. UK Nuclear Medicine Radioisotopes Revenue Growth 2019-2024 ($ Millions)
Figure 68. Italy Nuclear Medicine Radioisotopes Revenue Growth 2019-2024 ($ Millions)
Figure 69. Russia Nuclear Medicine Radioisotopes Revenue Growth 2019-2024 ($ Millions)
Figure 70. Middle East & Africa Nuclear Medicine Radioisotopes Sales Market Share by Country in 2023
Figure 71. Middle East & Africa Nuclear Medicine Radioisotopes Revenue Market Share by Country in 2023
Figure 72. Middle East & Africa Nuclear Medicine Radioisotopes Sales Market Share by Type (2019-2024)
Figure 73. Middle East & Africa Nuclear Medicine Radioisotopes Sales Market Share by Application (2019-2024)
Figure 74. Egypt Nuclear Medicine Radioisotopes Revenue Growth 2019-2024 ($ Millions)
Figure 75. South Africa Nuclear Medicine Radioisotopes Revenue Growth 2019-2024 ($ Millions)
Figure 76. Israel Nuclear Medicine Radioisotopes Revenue Growth 2019-2024 ($ Millions)
Figure 77. Turkey Nuclear Medicine Radioisotopes Revenue Growth 2019-2024 ($ Millions)
Figure 78. GCC Country Nuclear Medicine Radioisotopes Revenue Growth 2019-2024 ($ Millions)
Figure 79. Manufacturing Cost Structure Analysis of Nuclear Medicine Radioisotopes in 2023
Figure 80. Manufacturing Process Analysis of Nuclear Medicine Radioisotopes
Figure 81. Industry Chain Structure of Nuclear Medicine Radioisotopes
Figure 82. Channels of Distribution
Figure 83. Global Nuclear Medicine Radioisotopes Sales Market Forecast by Region (2025-2030)
Figure 84. Global Nuclear Medicine Radioisotopes Revenue Market Share Forecast by Region (2025-2030)
Figure 85. Global Nuclear Medicine Radioisotopes Sales Market Share Forecast by Type (2025-2030)
Figure 86. Global Nuclear Medicine Radioisotopes Revenue Market Share Forecast by Type (2025-2030)
Figure 87. Global Nuclear Medicine Radioisotopes Sales Market Share Forecast by Application (2025-2030)
Figure 88. Global Nuclear Medicine Radioisotopes Revenue Market Share Forecast by Application (2025-2030)
